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Ultra-high molecular weight polyethylene (UHMWPE) wear particles from artiﬁcial joints induce osteolysis and the subsequent loosening of
implants. Studies have reported that particles in the size range of 0.1–10 μm are the most biologically active in macrophage immune response. To
develop prosthetic joints with greater longevity and durability, it is crucial to understand the deleterious effects of wear particles. In this study, to
evaluate the effects of particle size on the activities of human monocyte-derived macrophages (HMDMs), seven differently sized particles of
polymethylmethacrylate (PMMA), in the range of 0.1–20 μm, were prepared. Viability and the secretion of cytokines were evaluated after
phagocytosis of each size particles by HMDMs. Differences in the viability of HMDMs after phagocytosis of particles sized 0.16–9.6 μm were
statistically signiﬁcant. Proinﬂammatory cytokine production of both tumor necrosis factor-α and interleukin-6 by HMDMs was strongly induced
by 0.8 μm PMMA particles. Consistent with the fact that macrophages are known to respond to pathogens measuring approximately 1.0 μm in
size, in this study, PMMA particles measuring 0.8 μm in size induced an immune response. This work provides fundamental data for the
designing of surface proﬁles of prosthetic joints, Which may expect the lower incidence of immune response.
& 2016 Southwest Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Several studies have reported the phagocytosis of ultra-high
molecular weight polyethylene (UHMWPE) wear particles from
artiﬁcial joints by macrophages [1–5]. Macrophages release
cytokines that stimulate osteoclasts, thereby resulting in bone
resorption [2,6,7]. UHMWPE wear particles induce osteolysis
and the subsequent loosening of implants, which are the main
factors of aseptic revision. Phagocytosis of particles by macro-
phages represents an important component of the cellular
response to implants. UHMWPE particles within a size range
of 0.1–10 μm are known to be the most biologically active [8–/10.1016/j.bsbt.2016.02.003
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nder responsibility of Southwest Jiaotong University.10]. In particular, particles measuring less than 1.0 μm in size
are thought to induce biological responses and stimulate
macrophages to produce inﬂammatory mediators such as
interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis
factor-α (TNF-α) [2,4,11,12]; these study ﬁndings indicate that
the size of the wear particles is an important parameter. In this
regard, previous studies have proposed that the nano-level
surface texture of the Co–Cr–Mo alloy would ensure both, a
larger size of UHMWPE wear particles and minimization of the
wear of UHMWPE, which is expected to inhibit the biological
activity of macrophages [13]. However, it is not clear that
particle size affects on biological response. With an aim to
design a surface proﬁle to ensure lower incidence of osteolysis
and aseptic loosening of implants, this study investigated the
effect of the particle morphology, especially the particle size, on
immune responses of human monocyte-derived macrophages.
Furthermore, this study attempted to determine the particle sizevier B.V. This is an open access article under the CC BY-NC-ND license
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ing viability and the secretion of proinﬂammatory cytokines in
macrophages after they phagocytosed particles of each size.2. Materials and Methods
2.1. Preparation of narrow-dispersion
polymethylmethacrylate (PMMA) particles
To unveil the relationship between particle size and biolo-
gical response, narrow-dispersion (PMMA) particles (Soken
Chemical & Engineering Co., Ltd., Japan) were used instead of
UHMWPE wear particles. Spherical particles with a mean size
of 0.16, 0.43, 0.8, 1.6, 5.6, 9.6 and 19.3 μm were prepared.
The 0.16 and 0.43 μm particles were composed of cross-linked
PMMA and the others were composed of non-cross-linked
PMMA. Fig. 1 showed the scanning electron micro scope
(SEM; JSM-6390LV, JEOL Ltd., Japan) images of PMMA
particles. Particles of each size were washed with 70% ethanol.
The particles were suspended in phosphate-buffered saline
(PBS (-)), which made by dissolving sodium dihydrogenpho-
sphate dihydrate (199-02825, Wako Pure Chemical Industries,
Ltd., Japan), disodium hydrogenphosphate 12-Water (196-
02835, Wako Pure Chemical Industries, Ltd., Japan) and
sodium chloride (192-13925, Wako Pure Chemical Industries,
Ltd., Japan) in distilled water, in order to obtain an initial
concentration of 50 μg/μL. To disperse the aggregated ﬁne
particles, the suspensions were treated with ultrasonic waves
using Bioruptor (UCD-250, Cosmo Bio Co., Ltd., Japan).Fig. 1. SEM image of PMMA particles2.2. Preparation of macrophages
Human monocyte-derived macrophages (HMDMs) obtained
from healthy volunteer donors were used in the present study.
Informed written consent was obtained from all donors. The
preparation procedure for the cells is shown in Fig. 2.
Peripheral blood (35 mL) was collected from healthy donors.
Fifteen milliliter of PBS ( ) with 1 mM ethylenediamine-N,
N,N0,N0-tetraacetic acid, disodium salt, dihydrate (EDTA 2NA;
34501861, Dojindo Molecular Technologies, Inc., Japan) was. Particle sizes were 0.16–19.3 μm.
Fig. 2. Procedure for the preparation of HMDMs.
Fig. 3. Procedure detailing the evaluation of HMDMs activation. Asterisk (*)
shows the method for collecting culture supernatants.
Fig. 4. The procedure of ELISA for the evaluation of proinﬂammatory
cytokine secretion.
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centrifugation at 200g (1500 rpm) for 35 min using the general
purpose refrigerated centrifuge (5920, KUBOTA Co., Japan).
Thirty ﬁve milliliter of blood cells diluted by PBS (-) with
1 mM EDTA blood cells were layered on top of 10 mL of
Lymphoprep™ (1114547, Axis-Shield Diagnostics Ltd., UK).
The layered blood cells were centrifuged at 200g (1500 rpm)
for 35 min, following which three separate components were
obtained: blood platelets, mononuclear cells, and red blood
cells. Of these components, the mononuclear cells were
extracted. The mononuclear cells (50 mL) was diluted with
PBS ( ) with 1 mM EDTA and then centrifuged at 200g
(1500 rpm) for 10 min, following which two separate layers
were obtained: the lymphocyte layer and the monocyte layer.
CD14þ monocytes were puriﬁed by positive selection via
magnetic-activated cell sorting technology (130-150-201, Mil-
tenyi Biotec, Germany) as described previously [14]. The
monocytes were added to 20 mL of Dulbecco's modiﬁed
Eagle's medium (DMEM; 041-29775, Wako Pure Chemical
Industries, Ltd., Japan) supplemented with 2% fetal bovine
serum (FBS; 172012-500ML, 12E183-A, Sigma), 100 U/mLpenicillin and 100 μg/mL streptomycin (168-23191, Wako
Pure Chemical Industries, Ltd., Japan). The culture medium
was divided into two 100 mm PRIMARIA™ tissue culture
dishes (353803, BD Falcon, USA). Ten nanogram/milliliter
granulocyte-macrophage colony-stimulating factor (GM-CSF;
075-04114, Wako Pure Chemical Industries, Japan) or
50 ng/mL macrophage colony stimulating factor (M-CSF;
139-13613, Wako Pure Chemical Industries, Japan) was
applied to each dish and incubated for 7 days to differentiate
the monocytes into macrophages. Macrophages that were
mixed each chemical induced macrophage were used as
HMDMs in this study.
2.3. Phagocytosis of PMMA particles by HMDMs
Fifty microgram/microliter PBS ( ) containing PMMA
particles was diluted to 1.0 μg/μL with culture medium:
DMEMs supplemented with 2% FBS, 100 U/mL penicillin
and 100 μg/mL streptomycin. HMDMs were seeded on an 8-
well chamber slide (354118, Corning Inc., USA) at a density of
1 105 cells/well. One hundred microliter of culture medium
containing PMMA particles (100 μg of PMMA particles of each
size) was injected into each well. After exploring the particles
for 5 h, phagocytosis activity of HMDMs stained with hema-
toxylin (1.04302.0025, Merck Millipore, Germany) and eosin
(1.15935.0025, Merck Millipore, Germany) was observed with
a light microscope (BX51, Olympus Co., Japan).
2.4. Effect of the amount of PMMA particles and the size of
the particles on cell viability
To investigate the cytotoxicity of PMMA particles on
HMDMs, the lactate dehydrogenase (LDH) cytotoxicity assay
Fig. 5. Optical microscopic images of HMDMs cultured with PMMA particles of each size for 5 h using an inverted phase-contrast microscope. The particle sizes
were 0.16, 0.43, 0.8, 1.6, 5.6, 9.6 and 19.3 μm, and a control image means applying no particles as control.
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HMDMs were seeded on a PRIMARIA™ 96-well plate
(353873, Corning Inc., USA) at a density of 1 104 cells/well
and incubated for 2 or 3 days to ensure sufﬁcient cell adhesion.
An aliquot of 50 μg/μL of PMMA particle in PBS ( ) was
diluted to 1.0, 3.0 and 5.0 μg/μL with culture medium,
respectively. After the culture medium was removed, 100 μL
of culture medium with each concentration of PMMA particles
was injected into each well. Therefore, we applied 100, 300
and 500 μg/well of PMMA particles to HMDMs, and the cellswere incubated for 24, 48, and 72 h. After incubation, culture
supernatants in each well were collected and cell viability was
analyzed by the LDH cytotoxicity Test kit (299-50601, Wako
Pure Chemical Industries, Ltd., Japan). In this test, the super-
natant of cells that were incubated without PMMA particles
was used as the negative control. For the positive control,
culture supernatant of cells incubated with culture medium
containing 1% polyoxyethylene sorbitan monolaurate (28353-
85, Nacalai Tesque, Inc., Japan) for 1 h after incubation with
culture medium alone for 23 h was used.
Fig. 6. Optical microscopic images of HMDMs cultured with PMMA particles of each size for 5 h using an inverted phase-contrast microscope. HMDMs were
stained with hematoxylin and eosin. The particle sizes were 0.16, 5.6, 9.6 and 19.3 μm, and a control image means applying no particles as control.
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Subsequently, the coloring solution was applied to each well
and it was allowed to react for 10 min at room temperature,
following which the optical density of each well was mea-
sured. The negative control indicated 100% cell viability and
the positive control indicated 0% cell viability.
2.5. Effect of particle size on proinﬂammatory cytokine
production
A ﬂow chart of the method for collecting culture supernatants
was the same as that asterisk (*) shown in Fig. 3. For evaluating
the effects of each particle size on biological responses, the
proinﬂammatory cytokines, which were IL-1β, IL-6 and TNF-α,
in the supernatants were assayed by enzyme-linked immunosor-
bent assay (ELISA) kits: human IL-1β ELISA kit (88-7010-22,
eBioscience, USA)，human IL-6 ELISA kit (88-7066-22,
eBioscience, USA) and human TNF-α ELISA kit (88-7346-88,
eBioscience, USA). HMDMs were seeded on a PRIMARIA™
96-well plate at a density of 1 104 cells/well. Two hundred
microliter of culture medium containing PMMA particles at aconcentration of 1.5 μg/μL (approximately 300 μg/well of
PMMA) was added to each well in incubated for 24, 48, 72 h.
After incubation, culture supernatants in each well were collected.
The culture supernatant of cells incubated without particles was
used as the negative control, while the culture supernatant of cells
incubated with culture medium containing 0.1 μg/mL lipopoly-
saccharide (LPS) solution was used as the positive control.
The procedure of ELISA for evaluating the production of
IL-1β, IL-6, and TNF-α was shown in Fig. 4. Each well of a
Maxisorp nunc-immuno 96-well plate (442404, Thermo Fisher
Scientiﬁc Inc., USA) was coated with a capture anti-body and
incubated for 24 h at 4 1C. The remaining protein-binding sites
in the coated wells were blocked by adding blocking buffer,
followed by incubation for 1 h at room temperature. The
collected culture supernatant was added to each well and
incubated for 2 h at room temperature. A detection antibody
was added to each well and incubated for 1 h at room
temperature. Avidin-HRP was added to each well and incu-
bated for 30 min at room temperature, following which TMB
solution was added. Finally, the optical density was measured
at 450 nm.
Fig. 7. Viability of HMDMs obtained from three donors after 24 h of incubation with PMMA particles of different sizes. The particles sizes were 0.16, 0.43, 0.8,
1.6, 5.6, 9.6 and 19.3 μm, and the amounts of the injection were 100, 300, and 500 μg, respectively. NC denotes negative control. The data are presented as
meanþSD. Statistical signiﬁcance was evaluated by non-repeated measures one-way analysis of variance (ANOVA); asterisk (*) means po0.05.
H. Chikaura et al. / Biosurface and Biotribology 2 (2016) 18–25 233. Results
Phagocytosis of PMMA particles by HMDMs is shown in
Fig. 5. The images of HMDMs after applying each size group
of the PMMA particles to the induced HMDMs for 5 h were
taken using an inverted phase-contrast microscope. Fig. 6
shows the images of hematoxylin and eosin-stained HMDMs.
It was observed that the phagocytosis of PMMA particles by
HMDMs was not dependent on the size of the PMMA
particles. It was also observed a higher number phagocytosis
of the relatively smaller-sized PMMA particles by HMDMs.
Fig. 7 shows the effect of various particle sizes on the viability
of HMDMs. The differences in the viability of cells that exposed
PMMA particles measuring 0.16–9.6 μm in size were statistically
signiﬁcant among all donors.
Secretion of the proinﬂammatory factors, IL-1β, IL-6 and
TNF-α, by HMDMs stimulated by PMMA particles of different
sizes is shown in Fig. 8. In case of the phagocytosis of 0.8 μmPMMA particles, IL-6 and TNF-α were produced at signiﬁcantly
higher levels. Furthermore, secretion of IL-1β was activated by
the phagocytosis of 0.8 μm particles, depending on the donor. In
contrast, in the case of particles of other sizes, secretion of
cytokines was not affected.
Fig. 9 shows the relationship between the secretion of proin-
ﬂammatory cytokines and the incubation time. The particles did
not show any statistically signiﬁcant differences with respect to
proinﬂammatory cytokine secretion at each incubation time. This
indicates that HMDMs were stimulated with the particles within
24 h of incubation. Only particles measuring 0.8 μm in size
showed signiﬁcantly enhanced cytokine secretion.4. Discussion
This study investigated the particle morphology, especially
the particle size, which induces the most hazardous biological
response by analyzing cell viability and the secretion of
Fig. 8. Effect of the sizes of the PMMA particles on secretions of IL-1β, IL-6 and TNF-α from the HMDMs obtained from three donors after 24 h of incubation.
NC and PC denote negative and positive control, respectively. The data are presented as meanþSD. Statistical signiﬁcance was evaluated by non-repeated measures
one-way analysis of variance (ANOVA); asterisk (*) means po0.05.
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obtain the range of submicron to micron size of narrow
distribution particles. The sizes from 0.1 to 20 μm of spherical
PMMA particles, which collected from artiﬁcial joint [1,15],
were used instead of the UHMWPE wear particle in this study.
The surface properties such as zeta potential, hydrophobic
surface or hydrophilic surface, morphology and surface area
affect amount of protein adhesion and subsequently the
phagocytosis capacity [16–19]. On the other hand, particle
morphology also affects secrete the proinﬂammatory regard-
less protein adhesion [20,21].
In this study, the amounts of PMMA particles applied to
HMDMs were 100, 300, and 500 μg/well. These amounts of
PMMA particles were estimated to be the same as those of
UHMWPE wear particles released from the Charnley hip
prosthesis in a period of 1 month [22]. Figs. 7–9 indicated that
the immune responses were dependent on the size of the PMMA
particles. In this study, proinﬂammatory cytokine production by
HMDMs was strongly induced by 0.8 μm PMMA particles.
Macrophages are known to respond to pathogens measuring
0.8 μm in size. In this study, PMMA particles measuring
approximately 1.0 μm in size also induced an immune response.
Therefore, macrophages are considered to have the capacity to
recognize a foreign body of an appropriate size and stimulate the
relevant biological responses.
Researchers have suggested that the cellular responses to
particles may vary with the number and surface area of the
particles [4,7,23]. Although a ﬁxed amount of particles was
adopted in this study, the total number of particles and thesurface area of the particles varied depending on the particle
size. For example, for the PMMA particle amount of 300 μg/
well, the surface area was 9.5 109 μm2 and the number of
particles was 1.2 1011 for 0.16 μm particles; however, in the
case of 19.3 μm particles, the surface area was 7.8 107 μm2
and the number of particles was 6.7 104. It is also necessary
to investigate that the effect of these parameters on biological
response.
The PMMA material used in this study was different from
implant materials such as UHMWPE, however, these particles
were recognized as similar size foreign body and subsequently
phagocytosis by HMDMs, which in turn stimulate different
biological responses. It is, however, unclear whether macro-
phages have the capacity to recognize particle size. Based on
our results, it appears that the magnitude of the biological
responses, which are cell cytotoxicity and cytokine secretion,
may vary depending on the particle size. Particles larger than
1 μm in size regulated the production of proinﬂammatory
cytokines, which indicated a reduction in the inhibition of
biological activation; this, in turn, resulted in a reduction in
bone resorption.
5. Conclusions
Macrophages phagocytosed PMMA particles of various sizes
(i.e., 0.16, 0.43, 0.8, 1.6, 5.6, 9.6, and 19.3 μm); however, their
effects on macrophages were different. PMMA particles measur-
ing 0.16–9.6 μm in size affected the viability of HMDMs. Only
0.8 μm PMMA particles stimulated the HMDMs to enhance the
Fig. 9. Effect of the sizes of the PMMA particles on secretions of IL-1β, IL-6,
and TNF-α from the HMDMs after 24, 48 and 72 h of incubation. NC and PC
denote negative and positive control, respectively.
H. Chikaura et al. / Biosurface and Biotribology 2 (2016) 18–25 25secretion of IL-6 and TNF-α. PMMA particles larger than 1.0 μm
may inhibit immune responses. The data obtained in this study
may be crucial in the development of artiﬁcial joints that inhibit
these biological responses.
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